Cabot (CBT) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CBT shares.
View CBT analyst ratings or view top-rated stocks.

4 equities research analysts have issued 1-year price targets for Cabot's shares. Their CBT share price forecasts range from $70.00 to $103.00. On average, they anticipate the company's share price to reach $83.75 in the next year. This suggests a possible upside of 25.0% from the stock's current price.
View analysts price targets for CBT or view top-rated stocks among Wall Street analysts.

Cabot's stock was trading at $66.84 at the beginning of 2023. Since then, CBT stock has increased by 0.3% and is now trading at $67.02.
View the best growth stocks for 2023 here.

Cabot saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 551,900 shares, a decline of 6.1% from the August 15th total of 587,500 shares. Based on an average daily trading volume, of 312,500 shares, the days-to-cover ratio is currently 1.8 days. Approximately 1.0% of the company's stock are short sold.
View Cabot's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our CBT earnings forecast.

Cabot Co. (NYSE:CBT) released its quarterly earnings data on Monday, August, 7th. The specialty chemicals company reported $1.42 EPS for the quarter, missing analysts' consensus estimates of $1.56 by $0.14. The specialty chemicals company had revenue of $968 million for the quarter, compared to the consensus estimate of $1.09 billion. Cabot had a trailing twelve-month return on equity of 25.98% and a net margin of 7.48%. The firm's revenue for the quarter was down 15.8% on a year-over-year basis. During the same period in the prior year, the company earned $1.73 EPS.

Cabot declared a quarterly dividend on Friday, July 14th. Shareholders of record on Friday, August 25th will be paid a dividend of $0.40 per share on Friday, September 8th. This represents a $1.60 annualized dividend and a dividend yield of 2.39%. The ex-dividend date is Thursday, August 24th.
Read our dividend analysis for CBT.

ETFs with the largest weight of Cabot (NYSE:CBT) stock in their portfolio include Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ).Global X Autonomous & Electric Vehicles ETF (DRIV).

Cabot (NYSE:CBT) pays an annual dividend of $1.60 per share and currently has a dividend yield of 2.33%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 30.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CBT will have a dividend payout ratio of 25.40% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CBT.

Cabot updated its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share guidance of $5.13-$5.28 for the period, compared to the consensus EPS estimate of $5.59. The company issued revenue guidance of -.

40 employees have rated Cabot Chief Executive Officer Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among the company's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.20%), Earnest Partners LLC (5.52%), State Street Corp (3.33%), Snyder Capital Management L P (3.11%), Dimensional Fund Advisors LP (2.20%) and Geode Capital Management LLC (1.96%). Insiders that own company stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita and Sean D Keohane.
View institutional ownership trends.

Shares of CBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBT stock can currently be purchased for approximately $67.02.

Cabot (NYSE:CBT) has a market capitalization of $3.75 billion and generates $4.32 billion in revenue each year. The specialty chemicals company earns $209 million in net income (profit) each year or $5.29 on an earnings per share basis.

The company employs 4,200 workers across the globe.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for the company is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at steve.delahunt@cabotcorp.com, or via fax at 617-342-6103.